Cover Image

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>

Polymyxins are commonly used as the last resort for the treatment of MDR <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> nosocomial infections; however, apart from the already known toxicity issues, resistance to these agents is emerging. In the present study,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paraskevi Mantzana (Author), Efthymia Protonotariou (Author), Angeliki Kassomenaki (Author), Georgios Meletis (Author), Areti Tychala (Author), Eirini Keskilidou (Author), Maria Arhonti (Author), Charikleia Katsanou (Author), Aikaterini Daviti (Author), Olga Vasilaki (Author), Georgia Kagkalou (Author), Lemonia Skoura (Author)
Format:	Book
Published:	MDPI AG, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Replacement of the Double Meropenem Disc Test with a Lateral Flow Assay for the Detection of Carbapenemase-Producing Enterobacterales and <i>Pseudomonas aeruginosa</i> in Clinical Laboratory Practice
by: Areti Tychala, et al.
Published: (2023)

Rapid Reversal of Carbapenemase-Producing <i>Pseudomonas aeruginosa</i> Epidemiology from <i>bla</i><sub>VIM</sub>- to <i>bla</i><sub>NDM</sub>-harbouring Isolates in a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2024)

Probable Three-Species In Vivo Transfer of <i>bla</i><sub>NDM-1</sub> in a Single Patient in Greece: Occurrence of NDM-1-Producing <i>Klebsiella pneumoniae</i>, <i>Proteus mirabilis</i>, and <i>Morganella morganii</i>
by: Georgios Meletis, et al.
Published: (2023)

Polyclonal Endemicity of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in ICUs of a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2022)

Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria
by: Georgios Meletis, et al.
Published: (2024)

Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response
by: Areti Tychala, et al.
Published: (2021)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
by: Andria Papazachariou, et al.
Published: (2024)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant <i>Enterobacterales</i>
by: Yi-Yun Liu, et al.
Published: (2022)

Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant <i>Acinetobacter baumannii</i>
by: Elif Odabaş Köse, et al.
Published: (2023)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022)

Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of <i>Escherichia coli</i> and <i>Acinetobacter baumannii</i>
by: Soraya Herrera-Espejo, et al.
Published: (2024)

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant <i>A.</i><i>baumannii</i> in Cancer Patient
by: Wasan Katip, et al.
Published: (2021)

Susceptibility Testing of Colistin for <i>Acinetobacter baumannii</i>: How Far Are We from the Truth?
by: Federica Sacco, et al.
Published: (2021)

The Effect of Colistin Treatment on the Selection of Colistin-Resistant <i>Escherichia coli</i> in Weaner Pigs
by: Shahana Ahmed, et al.
Published: (2021)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Emergence of Colistin-Resistant <i>Acinetobacter junii</i> in China
by: Zhiren Wang, et al.
Published: (2022)

Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
by: Wasan Katip, et al.
Published: (2022)

Involvement of <i>hpap2</i> and <i>dgkA</i> Genes in Colistin Resistance Mediated by <i>mcr</i> Determinants
by: Alejandro Gallardo, et al.
Published: (2020)

Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the <i>lpxD</i> Gene in <i>Acinetobacter baumannii</i>
by: Neveen M. Saleh, et al.
Published: (2020)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Filomena Sannio, et al.
Published: (2022)

First Description of Colistin and Tigecycline-Resistant <i>Acinetobacter baumannii</i> Producing KPC-3 Carbapenemase in Portugal
by: Cátia Caneiras, et al.
Published: (2018)

Synergistic Activity of Tetrandrine and Colistin against <i>mcr-1</i>-Harboring <i>Escherichia coli</i>
by: Muhammad Shafiq, et al.
Published: (2022)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020)

Absence of <i>mgrB</i> Alleviates Negative Growth Effects of Colistin Resistance in <i>Enterobacter cloacae</i>
by: Jessie E. Wozniak, et al.
Published: (2020)

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against <i>Acinetobacter baumannii</i> in Murine Severe Infections Models
by: Andrea Miró-Canturri, et al.
Published: (2021)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021)

Colistin Resistance Mechanisms in Human and Veterinary <i>Klebsiella pneumoniae</i> Isolates
by: Manuela Tietgen, et al.
Published: (2022)

XDR-<i>Pseudomonas aeruginosa</i> Outside the ICU: Is There Still Place for Colistin?
by: Paola Del Giacomo, et al.
Published: (2022)

In Vitro Synergism of Colistin and N-acetylcysteine against <i>Stenotrophomonas maltophilia</i>
by: Nagaia Ciacci, et al.
Published: (2019)

Enhancing Colistin Activity against Colistin-Resistant <i>Escherichia coli</i> through Combination with Alginate Nanoparticles and Small Molecules
by: Noura Hazime, et al.
Published: (2022)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020)

Molecular Detection of Colistin Resistance <i>mcr</i>-<i>1</i> Gene in Multidrug-Resistant <i>Escherichia coli</i> Isolated from Chicken
by: Md Bashir Uddin, et al.
Published: (2022)

Regulatory Landscape of the <i>Pseudomonas aeruginosa</i> Phosphoethanolamine Transferase Gene <i>eptA</i> in the Context of Colistin Resistance
by: Matteo Cervoni, et al.
Published: (2023)

Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes
by: Ioannis Andrianopoulos, et al.
Published: (2024)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients
by: Wasan Katip, et al.
Published: (2021)

Genomic Characteristics of Colistin-Resistant <i>Salmonella</i> <i>enterica</i> subsp. <i>enterica</i> Serovar Infantis from Poultry Farms in the Republic of Serbia
by: Branko Jovčić, et al.
Published: (2020)

Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical <i>Pseudomonas aeruginosa</i>
by: Valentina Laverde-Rojas, et al.
Published: (2020)